Curing brain tumors: blocking functions in cells with a docked molecule
medicalxpress.com
medicalxpress.com
Mebendazole, and others in its family, are also involved in a broken healthcare system in the US, where these medications costs between $0.07 and $10.00 per tablet in every other country, but there is a monopoly on manufacture that can price these tablets at $350 per tablet.
https://www.pharmachezvous.be/medicaments/vermifuge/vermox-c...
This sounds like covid-19 and ivermectin.
https://www.nytimes.com/2020/02/25/opinion/repurposing-drugs...
From "Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers", 2023:
> Mebendazole can penetrate the blood-brain barrier and has been shown to inhibit the malignant progression of glioma by targeting signaling pathways related to cell proliferation, apoptosis, or invasion/migration, or by increasing the sensitivity of glioma cells to conventional chemotherapy or radiotherapy.
https://pubmed.ncbi.nlm.nih.gov/36674870/
From "Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme", 2011:
> Our findings indicate that mebendazole is a possible novel anti-brain tumor therapeutic that could be further tested in clinical trials.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158014/
"Surprise Finding Yields a Possible Tumor-Fighting Drug", 2014:
> Searching the literature, they found reports that fenbendazole had been shown to inhibit cancer growth. Then, by trial and error, they determined that the related drug mebendazole—which has been used for the last 60 years to treat parasites in the human gastrointestinal tract—might also hold potential for stalling glioblastoma.
https://www.cancer.columbia.edu/news/promising-treatment-dea...
And, you _do_ hear of people using these antihelmintics, in conjunction with conventional cancer therapies, for treating their disease. There is a large community on Reddit around the Joe Tippens protocol, who has never been disproved.
> His next sentence almost floored me. He said, "You know, we’ve known for decades that these anthelmintic class of drugs (meaning to destroy parasites in the intestines) could have possible efficacy against cancer, and in fact in the 80's and 90's there was a drug called Levamisole that was used on colon cancer and it is an anthelmintic drug".
> I said, "Doc, if you have known for decades why hasn’t more work been done on it?" His answer was honest. He said, "probably because of money…all of these drugs are far off-patent and nobody is going to spend a gazillion dollars to repurpose them for cancer...only to have generic competition the next day."
https://mycancerstory.rocks/the-blog/
See also: "Repurposing Drugs to Fight Cancer", 2020
https://www.nytimes.com/2020/02/25/opinion/repurposing-drugs...
And I entirely agree with your other point: university press releases are notorious for hyping research. It does the biomedical field a disservice, and gives the impression clinical trials are but an afterthought. Nothing could be further from the truth.
Getting promising drugs into humans is -hard-, and this research is interesting, but this press release is still kind of shitty.
That said, the bar for human glioblastoma trials is very low. There is no cure and the disease is 100% fatal. After the standard of care treatment (which hasn't changed in 10 years), patients enter a period of regular brain scans, waiting for the inevitable recurrence and the next step down in quality of life.
A lot has changed in 10 years for the 'standard of care' conventional treatments (RT + TMZ) although most active-treatment GBM cases will actually be on some experimental therapy/clinical trial.
In fact, the WHO classification was only recently updated (2021) as what we were calling GBM included different types of gliomas with very different prognostic implications.
Unfortunately, as you allude to, despite several advancements prognosis has only marginally improved over 10 years. The main issue is that these patients almost always present with symptoms (like seizures) by which point curative intent ablative therapies (radiation or surgery) are no longer possible due to intolerable side effects.
> waiting for the inevitable recurrence
It's more progression than recurrence, there is (essentially) always residual disease with GBM even after radiotherapy/surgery which is one of the main reasons it remains so fatal (~6-9 months). Because of the blood-brain barrier chemotherapeutic options are also very limited.
I remember when reovirus and modified adenovirus were supposed to be the ticket for glio. Such a terrible thing, hope this is faster to the mark than my jaded forecast.
2 year survival doesn’t sound like a lot but considering the study included non-mutated GBM (the worst kind) this prognosis is ~3-4x longer than with current treatment options.
GBM (IDH-wt) is, unfortunately, extremely aggressive and not uncommon. Arguably the worst type of cancer for an adult.
As a small silver lining the dismal prognosis means experimental therapies are possible on compassionate grounds and trials are expedited. We’ve also gotten much better as histologically and radiologically evaluating the disease. I’m cautiously optimistic it won’t be the immediate death sentence it currently is within my career, but it does appear we are still a few breakthroughs away from that being possible.